You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CME / ABIM MOC / CE

Do Children With Strabismus Have an Increased Risk for Mental Illness?

  • Authors: News Author: Pauline Anderson; CME Author: Charles P. Vega, MD
  • CME / ABIM MOC / CE Released: 4/29/2022
  • Valid for credit through: 4/29/2023
Start Activity

  • Credits Available

    Physicians - maximum of 0.25 AMA PRA Category 1 Credit(s)™

    ABIM Diplomates - maximum of 0.25 ABIM MOC points

    Nurses - 0.25 ANCC Contact Hour(s) (0 contact hours are in the area of pharmacology)

    Physician Assistant - 0.25 AAPA hour(s) of Category I credit

    IPCE - 0.25 Interprofessional Continuing Education (IPCE) credit

    You Are Eligible For

    • Letter of Completion
    • ABIM MOC points

Target Audience and Goal Statement

This activity is intended for primary care physicians, pediatricians, psychiatrists, ophthalmologists, nurses, physician assistants, and other members of the healthcare team who treat and manage children with strabismus.

The goal of this activity is that learners will be able to distinguish forms of mental illness associated with strabismus among children.

Upon completion of this activity, participants will:

  • Assess how corrective surgery for strabismus can affect quality of life
  • Analyze the relationship between strabismus and mental illness among children
  • Outline implications for the healthcare team


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated according to Medscape policies. Others involved in the planning of this activity have no relevant financial relationships.


News Author

  • Pauline Anderson

    Freelance writer, Medscape

    Disclosures

    Disclosure: Pauline Anderson has disclosed no relevant financial relationships.

CME Author

  • Charles P. Vega, MD

    Health Sciences Clinical Professor of Family Medicine
    University of California, Irvine School of Medicine
    Irvine, California

    Disclosures

    Disclosure: Charles P. Vega, MD, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: GlaxoSmithKline; Johnson & Johnson

Editor/Compliance Reviewer

  • Yaisanet Oyola, MD

    Associate Director, Accreditation and Compliance
    Medscape, LLC

    Disclosures

    Disclosure: Yaisanet Oyola, MD, has no relevant financial relationships.

Nurse Planner

  • Stephanie Corder, ND, RN, CHCP

    Associate Director, Accreditation and Compliance
    Medscape, LLC

    Disclosures

    Disclosure: Stephanie Corder, ND, RN, CHCP, has disclosed no relevant financial relationships.

Compliance Reviewer

  • Amanda Jett, PharmD, BCACP

    Associate Director, Accreditation and Compliance
    Medscape, LLC

    Disclosures

    Disclosure: Amanda Jett, PharmD, BCACP, has disclosed no relevant financial relationships.

PA Planner

  • Jennifer Hakkarainen, PA-C

    Medical Education Director, Medscape, LLC

    Disclosures

    Disclosure: Jennifer Hakkarainen, PA-C, has disclosed no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 0.25 Interprofessional Continuing Education (IPCE) credit for learning and change.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

    Contact This Provider

    For Nurses

  • Awarded 0.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 0 contact hours are in the area of pharmacology.

    Contact This Provider

  • For Physician Assistants

    Medscape, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.25 AAPA Category 1 CME credits. Approval is valid until 4/29/2023. PAs should only claim credit commensurate with the extent of their participation.

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / ABIM MOC / CE

Do Children With Strabismus Have an Increased Risk for Mental Illness?

Authors: News Author: Pauline Anderson; CME Author: Charles P. Vega, MDFaculty and Disclosures

CME / ABIM MOC / CE Released: 4/29/2022

Valid for credit through: 4/29/2023

processing....

Clinical Context

Strabismus affects 2% to 5% of US children and has been associated with higher rates of disability and reduced quality of life. But does corrective surgery for strabismus change these associations? Archer and colleagues performed a prospective cohort study to answer this question; their results were published in the April 2005 issue of the Journal of the American Association for Pediatric Ophthalmology and Strabismus.[1]

Parents of 98 children with a mean age of 4.5 years were asked to complete a quality-of-life instrument both before corrective surgery for strabismus and then 2 months postoperatively. Overall, there was good internal consistency within children completing the survey. Surgery was associated with improvements across nearly all domains of quality of life, including functional limitations, social relations, and general health perception. Interestingly, 1 of the 2 variables that was not improved with surgery was positive well-being.

Previous research has suggested that strabismus may be associated with a higher rate of mental illness, but these studies focused on smaller populations in specific locations. The current study takes a broader look at mental illness among children with strabismus.

Study Synopsis and Perspective

Misaligned eyes in children are associated with an increased prevalence of mental illness, results of a large study suggest.

Investigators found that children with strabismus or "crossed eyes" had up to a 2-fold increased risk of developing anxiety, depression, bipolar disorder, and schizophrenia compared with their counterparts without the eye condition.

"Psychiatrists who have a patient with depression or anxiety and notice that patient also has strabismus might think about the link between those 2 conditions and refer that patient," study investigator Stacy L. Pineles, MD, professor, Department of Ophthalmology, University of California at Los Angeles, told Medscape Medical News.

The study was published online March 10 in JAMA Ophthalmology.[2]

A Common Condition

Strabismus, a condition in which the eyes do not line up or are "crossed," is one of the most common eye diseases in children, with some estimates suggesting that it affects more than 1.5 million American youth.

Patients with strabismus have problems making eye contact and are affected socially and functionally, said Dr Pineles. They are often met with a negative bias, as shown by children's responses to pictures of faces with and without strabismus, she said.

There is a signal from previous research suggesting that strabismus is linked to a higher risk for mental illness. However, most of these studies were small and had relatively homogenous populations, said Dr Pineles.

The new study includes more than 12 million children (mean age, 8.0 years) from a private health insurance claims database that represents diverse races and ethnicities as well as geographic regions across the United States.

The sample included 352,636 children with strabismus and 11,652,553 children with no diagnosed eye disease who served as controls. Most participants were White (51.6%), came from a family with an annual household income of $40,000 or more (51.0%), had point-of-service insurance (68.7%), and had at least 1 comorbid condition (64.5%).

The study evaluated 5 mental illness diagnoses. These included anxiety disorder, depressive disorder, substance use or addictive disorder, bipolar disorder, and schizophrenia.

Overall, children with strabismus had a higher prevalence of all these illnesses with the exception of substance use disorder.

After adjusting for age, sex, race and ethnicity, census region, education level of caregiver, family net worth, and presence of at least 1 comorbid condition, the odds ratios (ORs) among those with versus without strabismus were 2.01 (95% confidence interval [CI], 1.99-2.04; P<.001) for anxiety disorder, 1.83 (95% CI, 1.76-1.90; P<.001) for schizophrenia, 1.64 (95% CI, 1.59-1.70; P<.001) for bipolar disorder, and 1.61 (95% CI, 1.59-1.63; P<.001) for depressive disorder.

Substance use disorder had a negative unadjusted association with strabismus, but after adjustment for confounders, the association was not significant (OR, 0.99; 95% CI, 0.97-1.02; P=.48).

Dr Pineles noted that the study participants, who were all younger than 19 years, may be too young to have substance use disorders.

The results for substance use disorders provided something of an "internal control" and reaffirmed results for the other 4 conditions, said Dr Pineles.

"When you do research on such a large database, you're very likely to find significant associations; the data set is so large that even very small differences become statistically significant. It was interesting that not everything gave us a positive association."

Researchers divided the strabismus group into those with esotropia, where the eyes turn inward (52.2%); exotropia, where they turn outward (46.3%); and hypertropia, where 1 eye wanders upward (12.5%). Investigators found that all 3 conditions were associated with increased risk for anxiety disorder, depressive disorder, bipolar disorders, and schizophrenia.

The investigators note that rates in the current study were lower than in previous studies, which showed that children with congenital esotropia were 2.6 times more likely to receive a mental health diagnosis and children with intermittent exotropia were 2.7 times more likely to receive a mental health diagnosis.

"It is probable that our study found a lower risk than these studies because our study was cross-sectional and claims based, whereas these studies observed the children to early adulthood and were based on medical records," the investigators note.

It is impossible to determine from this study how strabismus is connected to mental illness. However, Dr Pineles believes that depression and anxiety might be tied to strabismus via teasing, which affects self-esteem, although genetics could also play a role. For conditions such as schizophrenia, a shared genetic link with strabismus might be more likely, she added.

"Schizophrenia is a pretty severe diagnosis, so just being teased or having poor self-esteem is probably not enough" to develop schizophrenia.

Based on her clinical experience, Dr Pineles said that realigning the eyes of patients with milder forms of depression or anxiety "definitely anecdotally helps these patients a lot."

Dr Pineles and colleagues have another paper in press that examines mental illnesses and other serious eye disorders in children and shows similar findings, she said.

Implications for Insurance Coverage?

In an accompanying editorial, experts led by S. Grace Prakalapakorn, MD, from the Department of Ophthalmology and Pediatrics, Duke University Medical Center, Durham, North Carolina, noted the exclusion of children covered under government insurance or without insurance is an important study limitation, largely because socioeconomic status is a risk factor for poor mental health.[3]

The editorialists point to studies showing that surgical correction of ocular misalignments may be associated with reduced anxiety and depression. However, health insurance coverage for such surgical correction "may not be available owing to a misconception that these conditions are 'cosmetic,' " they note.

Evidence of the broader association of strabismus with physical and mental health "may play an important role in shifting policy to promote insurance coverage for timely strabismus care," they write.

As many mental health disorders begin in childhood or adolescence, "it is paramount to identify, address, and, if possible, prevent mental health disorders at a young age because failure to intervene in a timely fashion can have lifelong health consequences," conclude Dr Prakalapakorn and colleagues.

With mental health conditions and disorders increasing worldwide, compounded by the stressors of the COVID-19 pandemic, additional studies are needed to explore the causal relationships between ocular and psychiatric phenomena, their treatment, and outcomes, they add.

The study was supported by a grant from the National Eye Institute and an unrestricted grant from Research to Prevent Blindness. Dr Pineles has reported no relevant conflicts of interest. Commentary author Manpreet K. Singh, MD, has reported receiving research support from Stanford's Maternal Child Health Research Institute and Stanford's Department of Psychiatry and Behavioral Sciences, the National Institute of Mental Health, the National Institute on Aging, the Patient-Centered Outcomes Research Institute, Johnson & Johnson, Allergan, and the Brain and Behavior Research Foundation; serving on the advisory board for Sunovion and Skyland Trail; serving as a consultant for Johnson & Johnson; previously serving as a consultant for X, the moonshot factory, Alphabet, and Limbix Health; receiving honoraria from the American Academy of Child and Adolescent Psychiatry; and receiving royalties from American Psychiatric Association Publishing and Thrive Global. Commentary author Nathan Congdon, MD, has reported receiving personal fees from Belkin Vision outside the submitted work.

JAMA Ophthalmol. Published online March 10, 2022.

Study Highlights

  • Study data were drawn from an open, collaborative US research center with data on medical, pharmacy, and laboratory information on millions of US residents with either commercial health insurance or Medicare.
  • Patients in the database who had strabismus were compared with control patients who had no eye disease other than refractive error.
  • The main study outcome was mental illness, which was determined from diagnostic codes and included anxiety disorder, depressive disorder, substance use or addictive disorder, bipolar disease, and schizophrenia.
  • 12,005,189 patients were included in the study; 50.8% of patients were boys and the mean age of patients was 8.0 years. A total of 352,636 children had strabismus, and 11,652,553 did not.
  • Among children with strabismus, 50.1% were female and 51.6% were White.
  • After adjustment for demographic factors the odds ratios for mental illness associated with strabismus were as follows:
    • Anxiety disorder, 2.01 (95% CI, 1.99-2.04)
    • Schizophrenia, 1.83 (95% CI, 1.76-1.90)
    • Bipolar disorder, 1.64 (95% CI, 1.59-1.70)
    • Depressive disorder, 1.61 (95% CI, 1.59-1.63)
    • Substance use disorder, 0.99 (95% CI, 0.97-1.02)
  • Outcomes were generally similar, indicating a positive relationship between strabismus and mental illness in subgroup analyses assessing esotropia, exotropia, and hypertropia specifically.
  • However, exotropia was associated with a significantly lower rate of substance use disorder in adjusted analysis.

Clinical Implications

  • In a previous study of corrective surgery among children with strabismus, surgery was associated with improvements across nearly all domains of quality of life, including functional limitations, social relations, and general health perception. However, one variable that was not improved with surgery was positive well-being.
  • In the current study, strabismus among children was associated with higher rates of anxiety disorder, schizophrenia, bipolar disorder, and depressive disorder. Strabismus did not affect the rate of substance use disorders.
  • Outline implications for the healthcare team: The healthcare team should monitor the mental health of children with strabismus and promptly intervene if symptoms arise. The cross-sectional study by Lee et. al., suggests that “there was a moderate association between strabismus and anxiety disorder, schizophrenia, bipolar disorder, and depressive disorder but not substance use disorder” [2]. The healthcare team should recognize these associations and monitor mental illness screening and treatment for children and patients with strabismus.

 

Earn Credit

  • Print